These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 36439873)
1. Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC. Zhang JZ; Liu J; Xu YX; Pu WY; Shen MJ; Jiang KQ; Yang YL; Lu J; Deng Z; Yang Y; Xu WH Int J Biol Sci; 2022; 18(16):6163-6175. PubMed ID: 36439873 [TBL] [Abstract][Full Text] [Related]
2. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth. Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426 [TBL] [Abstract][Full Text] [Related]
3. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo. Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124 [TBL] [Abstract][Full Text] [Related]
4. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth. Han Q; Yan P; Song R; Liu F; Tian Q Cell Death Dis; 2023 Jul; 14(7):398. PubMed ID: 37407582 [TBL] [Abstract][Full Text] [Related]
5. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer. Peng SQ; Zhu XR; Zhao MZ; Zhang YF; Wang AR; Chen MB; Ye ZY Cell Death Dis; 2023 Feb; 14(2):157. PubMed ID: 36828810 [TBL] [Abstract][Full Text] [Related]
6. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth. Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803 [TBL] [Abstract][Full Text] [Related]
7. A first-in-class TIMM44 blocker inhibits bladder cancer cell growth. Zhang L; Shi X; Zhang L; Mi Y; Zuo L; Gao S Cell Death Dis; 2024 Mar; 15(3):204. PubMed ID: 38467612 [TBL] [Abstract][Full Text] [Related]
8. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer. Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253 [TBL] [Abstract][Full Text] [Related]
9. ADCK1 is a potential therapeutic target of osteosarcoma. Zhuo BB; Zhu LQ; Yao C; Wang XH; Li SX; Wang R; Li Y; Ling ZY Cell Death Dis; 2022 Nov; 13(11):954. PubMed ID: 36371387 [TBL] [Abstract][Full Text] [Related]
10. Identification of Gαi3 as a novel molecular therapeutic target of cervical cancer. Zhang J; Yin DP; Zhang Y; Zhang JN; Yang Y; Zhang ZQ; Zhou L; Lv Y; Huang HW; Cao C Int J Biol Sci; 2022; 18(15):5667-5680. PubMed ID: 36263185 [TBL] [Abstract][Full Text] [Related]
11. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer. Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734 [TBL] [Abstract][Full Text] [Related]
12. GDC-0349 inhibits non-small cell lung cancer cell growth. Yang H; Zhao J; Zhao M; Zhao L; Zhou LN; Duan Y; Li G Cell Death Dis; 2020 Nov; 11(11):951. PubMed ID: 33154352 [TBL] [Abstract][Full Text] [Related]
13. Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells. Liu X; Jiang Q; Liu H; Luo S Biol Res; 2019 Feb; 52(1):7. PubMed ID: 30797236 [TBL] [Abstract][Full Text] [Related]
14. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer. Li J; Cheng D; Zhu M; Yu H; Pan Z; Liu L; Geng Q; Pan H; Yan M; Yao M Theranostics; 2019; 9(1):179-195. PubMed ID: 30662561 [TBL] [Abstract][Full Text] [Related]
16. Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer. Jiang JZ; Qiao YB; Zhu XR; Gu QH; Lu JJ; Ye ZY; Xu L; Liu YY Cell Death Dis; 2024 Sep; 15(9):699. PubMed ID: 39349432 [TBL] [Abstract][Full Text] [Related]
17. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway. Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281 [TBL] [Abstract][Full Text] [Related]
18. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells. Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608 [TBL] [Abstract][Full Text] [Related]
19. Antihelminthic Niclosamide Induces Autophagy and Delayed Apoptosis in Human Non-small Lung Cancer Cells Chai WH; Li YR; Lin SH; Chao YH; Chen CH; Chan PC; Lin CH Anticancer Res; 2020 Mar; 40(3):1405-1417. PubMed ID: 32132037 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]